515 related articles for article (PubMed ID: 1690601)
1. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache.
Nicolodi M; Del Bianco E
Cephalalgia; 1990 Feb; 10(1):39-50. PubMed ID: 1690601
[TBL] [Abstract][Full Text] [Related]
2. Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients.
Bellamy JL; Cady RK; Durham PL
Headache; 2006 Jan; 46(1):24-33. PubMed ID: 16412148
[TBL] [Abstract][Full Text] [Related]
3. Nostril capsaicin application as a model of trigeminal primary sensory neuronal activation.
Nicolodi M
Cephalalgia; 1994 Apr; 14(2):134-8. PubMed ID: 7520365
[TBL] [Abstract][Full Text] [Related]
4. Effect of pilocarpine on substance P and calcitonin gene-related peptide releases correlate with salivary secretion in human saliva and plasma.
Sato Y; Itoh H; Suzuki Y; Tatsuta R; Takeyama M
J Clin Pharm Ther; 2013 Feb; 38(1):19-23. PubMed ID: 23030252
[TBL] [Abstract][Full Text] [Related]
5. Migraine and neuropeptides.
Tajti J; Szok D; Majláth Z; Tuka B; Csáti A; Vécsei L
Neuropeptides; 2015 Aug; 52():19-30. PubMed ID: 26094101
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of primary headaches.
Edvinsson L
Curr Pain Headache Rep; 2001 Feb; 5(1):71-8. PubMed ID: 11252141
[TBL] [Abstract][Full Text] [Related]
7. Substance P theory: a unique focus on the painful and painless phenomena of cluster headache.
Sicuteri F; Fanciullacci M; Nicolodi M; Geppetti P; Fusco BM; Marabini S; Alessandri M; Campagnolo V
Headache; 1990 Jan; 30(2):69-79. PubMed ID: 1689282
[TBL] [Abstract][Full Text] [Related]
8. Aspects on the pathophysiology of migraine and cluster headache.
Edvinsson L
Pharmacol Toxicol; 2001 Aug; 89(2):65-73. PubMed ID: 11555322
[TBL] [Abstract][Full Text] [Related]
9. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
10. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
[TBL] [Abstract][Full Text] [Related]
11. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies.
Goadsby PJ; Edvinsson L
Brain; 1994 Jun; 117 ( Pt 3)():427-34. PubMed ID: 7518321
[TBL] [Abstract][Full Text] [Related]
12. An exploratory study of salivary calcitonin gene-related peptide levels relative to acute interventions and preventative treatment with onabotulinumtoxinA in chronic migraine.
Cady R; Turner I; Dexter K; Beach ME; Cady R; Durham P
Headache; 2014 Feb; 54(2):269-77. PubMed ID: 24147647
[TBL] [Abstract][Full Text] [Related]
13. The co-localization of neuropeptides in the submucosa of the small intestine of normal Wistar and non-diabetic BB rats.
Pataky DM; Curtis SB; Buchan AM
Neuroscience; 1990; 36(1):247-54. PubMed ID: 1699158
[TBL] [Abstract][Full Text] [Related]
14. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin-gene related peptide and disease activity in cluster headache.
Snoer A; Vollesen ALH; Beske RP; Guo S; Hoffmann J; Fahrenkrug J; Jørgensen NR; Martinussen T; Jensen RH; Ashina M
Cephalalgia; 2019 Apr; 39(5):575-584. PubMed ID: 30854880
[TBL] [Abstract][Full Text] [Related]
17. Patients with lower motor spinal cord lesion: a decrease of vasoactive intestinal polypeptide, calcitonin gene-related peptide and substance P, but not neuropeptide Y and somatostatin-immunoreactive nerves in the detrusor muscle of the bladder.
Crowe R; Moss HE; Chapple CR; Light JK; Burnstock G
J Urol; 1991 Mar; 145(3):600-4. PubMed ID: 1705295
[TBL] [Abstract][Full Text] [Related]
18. Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats.
Belai A; Lincoln J; Burnstock G
Gastroenterology; 1987 Nov; 93(5):1034-40. PubMed ID: 2443415
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache.
Goadsby PJ; Edvinsson L; Ekman R
Ann Neurol; 1990 Aug; 28(2):183-7. PubMed ID: 1699472
[TBL] [Abstract][Full Text] [Related]
20. Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tension-type headache.
Marukawa H; Shimomura T; Takahashi K
Headache; 1996 Feb; 36(2):100-04. PubMed ID: 8742682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
